Table 3 Percentages of surviving and results of univariate Cox regression analysis
From: Perceval-S over time. Clinical outcomes after ten years of usage
Alive N = 142; 69.3% | Dead N = 63; 30.7% | HR (95% CI)+ | P | |
|---|---|---|---|---|
N (%) | N (%) | |||
Sex | ||||
Men | 47 (67.1) | 23 (32.9) | ||
Women | 95 (70.4) | 40 (29.6) | 0.81 (0.47–1.39) | 0.436 |
Age, mean (SD) | 76.6 (5.5) | 75.9 (7.1) | 0.98 (0.94–1.02) | 0.354 |
BSA, median (IQR) | 1.76 (1.64 ─ 1.92) | 1.78 (1.67 ─ 1.91) | 1.66 (0.46–6.05) | 0.440 |
EF%, mean (SD) | 52.5 (10.4) | 50.7 (10.2) | 0.98 (0.96–1.00) | 0.105 |
Valve size | ||||
Small | 20 (69.0) | 9 (31.0) | ||
Medium | 59 (70.2) | 25 (29.8) | 0.99 (0.43–2.30) | 0.981 |
Large | 40 (67.8) | 19 (32.2) | 0.90 (0.36–2.21) | 0.813 |
Extra large | 23 (69.7) | 10 (30.3) | 1.15 (0.44–3.02) | 0.777 |
Disease | ||||
Aortic valve stenosis | ||||
No | 11 (55.0) | 9 (45.0) | ||
Yes | 131 (70.8) | 54 (29.2) | 0.65 (0.31–1.38) | 0.265 |
Coronary artery disease | ||||
No | 103 (72.0) | 40 (28.0) | ||
Yes | 39 (62.9) | 23 (37.1) | 1.70 (0.99–2.94) | 0.055 |
Mixed valvulopathy / insufficiency | ||||
No | 130 (71.0) | 53 (29.0) | ||
Yes | 12 (54.5) | 10 (45.5) | 1.67 (0.82–3.40) | 0.158 |
Left main artery disease | ||||
No | 137 (69.2) | 61 (30.8) | ||
Yes | 5 (71.4) | 2 (28.6) | 1.37 (0.33–5.65) | 0.665 |
Surgery | ||||
AVR | 99 (72.3) | 38 (27.7) | ||
AVR + CABG | 39 (61.9) | 24 (38.1) | 1.82 (1.05–3.13) | 0.032 |
Other | 4 (80.0) | 1 (20.0) | 1.05 (0.14–7.70) | 0.962 |
Total procedural time min, mean (SD) | 184.6 (79) | 192.3 (75.5) | 1.04 (1.01–1.07) | 0.026 |
CPB time min, mean (SD) | 107.6 (68.6) | 110 (50.6) | 1.01 (0.97–1.05) | 0.553 |
Ischemia time min, mean (SD) | 64.2 (39.2) | 77.3 (94.0) | 1.02 (0.99–1.04) | 0.205 |
Lowest temperature | 32,7 (4, 9) | 32,6 (1, 7) | 0.99 (0.91–1.07) | 0.747 |
Cell SAVER | 621,4 (255,8) | 640,3 (269,5) | 1.05 (0.95–0.15) | 0.355 |